![Ellen M. Brady](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Ellen M. Brady
Analyst-Equity chez LifeTech Research, Inc.
Provenance du réseau au premier degré de Ellen M. Brady
Entité | Type d'entité | Industrie | |
---|---|---|---|
LifeTech Research, Inc.
![]() LifeTech Research, Inc. Investment Banks/BrokersFinance Founded in 2003, LifeTech Research, Inc. is an investment research, technology development and due diligence firm located in Edgewater, Maryland. The firm provides due-diligence and business development services across the life sciences sector. They advise business development offices on product licensing and acquisition strategies and they support early-stage entrepreneurs with disruptive ideas and technologies. LifeTech also assists international financing agencies to facilitate the granting and lending of capital to improve economic welfare and societal health. LifeTech's research methods include (1) benchmarking (2) historic trend and meta-analysis (3) bias assessment and adjustment (4) decision analysis and Monte Carlo simulation (5) scenario analysis, back-testing and other statistical validation (6) advanced regression modeling and (7) risk and time-adjusted present value modeling.
5
| Private Company | Investment Banks/Brokers | 5 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Ellen M. Brady via son réseau personnel
Société | Secteur | Personnes liées | Poste principal |
---|---|---|---|
The Johns Hopkins University | College/University | Masters Business Admin Doctorate Degree | |
C2N Diagnostics LLC
![]() C2N Diagnostics LLC BiotechnologyHealth Technology C2N Diagnostics LLC is a private company that focuses on mechanism-based approaches to prevent or stop the progression of human neurological disorders. The company is based in St. Louis, MO. The company's lead commercial product, PrecivityAD™, is a mass spectrometry-based test that measures in blood multiple analytes including a?42, a?40, and apolipoprotein e isoforms. This test predicts brain amyloid plaques as determined by PET scan results and received a breakthrough device designation from the Food and Drug Administration in early 2019. C2N Diagnostics aims to bring accurate, widely accessible, and cost-effective blood tests to the clinic for the betterment of patient care and brain health monitoring in the field of neurodegeneration and Alzheimer's disease. The company was founded by Ravi Kiron, Joel Bennett Braunstein, Ilana Fogelman. Joel Bennett Braunstein has been the CEO since incorporation. | Biotechnology | Founder Founder | |
LifeTech Development Partners LP
![]() LifeTech Development Partners LP Investment ManagersFinance LifeTech Development Partners LP (LifeTech Development) is a venture capital subsidiary of LifeTech Research, Inc. founded in 2008 by Joel Braunstein. The firm is headquartered in Baltimore, Maryland. | Investment Managers | Founder Private Equity Investor | |
The North Carolina Biotechnology Center
![]() The North Carolina Biotechnology Center Internet Software/ServicesTechnology Services The North Carolina Biotechnology Center provides research and education grants. Its services include financing, technology assessment, business planning, and marketing strategies implementation. The company was founded in 1984 and is headquartered in Research Triangle Park, NC. | Internet Software/Services | Corporate Officer/Principal | |
PRECISION BIOSCIENCES, INC. | Biotechnology | Corporate Officer/Principal | |
Guilford College | College/University | Undergraduate Degree | |
miCure Therapeutics Ltd | Chief Executive Officer | ||
Rare-X
![]() Rare-X Packaged SoftwareTechnology Services Part of Global Genes, Rare-X is a patient advocacy organization based in Washington. Rare-X is focused on supporting the acceleration and development of life-altering treatments and future cures for patients impacted by a rare disease. Rare-X is building the largest collaborative patient-driven, open-data access project for rare diseases ly, gathering structured, fit-for-purpose data to share broadly, benefitting from 21st-century governance, consent, and federated data sharing technology. Rare-X's goal is to build the largest collaborative patient-driven, open-data access project for rare diseases ly. The American company was founded in 2019 by Nicole Boice. The CEO is Charlene Son Rigby. Rare-X was acquired by Global Genes on February 07, 2023. | Packaged Software | Director/Board Member | |
Harvard University
![]() Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Graduate Degree | |
University of Sao Paulo | College/University | Doctorate Degree | |
Northwestern University
![]() Northwestern University Other Consumer ServicesConsumer Services Northwestern University is a private institution founded in 1851 to serve the Northwest Territory, an area that now includes the states of Ohio, Indiana, Illinois, Michigan, Wisconsin and parts of Minnesota. Northwestern has three campuses | College/University | Doctorate Degree | |
Centegen, Inc.
![]() Centegen, Inc. BiotechnologyHealth Technology Centegen, Inc. develops novel therapeutics to fight serious drug resistant bacterial infections. The company was founded by Dr. Joel B. Braunstein and is headquartered in Pikesville, MD. | Biotechnology | Chief Executive Officer | |
Sphera Funds Management Ltd. (US)
![]() Sphera Funds Management Ltd. (US) Investment ManagersFinance Sphera Funds Management Ltd. (US) (Sphera US) is the New York-based hedge fund management division of Sphera Funds Management Ltd., which is owned by S.R Accord Ltd. (TLV: SRAC), a company headquartered in Israel. Sphera US manages distinct long/short equity strategies. The firm has a diverse investor base that includes pensions, insurance companies, financial institutions and family offices. | Investment Managers | Director of Research - Equity | |
University of Calgary | College/University | Doctorate Degree | |
Bowdoin College
![]() Bowdoin College Other Consumer ServicesConsumer Services Bowdoin College is an independent, nonsectarian, coeducational residential, undergraduate liberal arts institution founded in 1794. It is located in Brunswick, ME. | College/University | Undergraduate Degree | |
Wexford Capital LP
![]() Wexford Capital LP Investment ManagersFinance Wexford Capital LP (Wexford) is an independent, SEC-registered investment advisor headquartered in West Palm Beach, Florida with additional office in Stamford, Connecticut. The firm was founded by Charles Davidson, Joseph Jacobs and Robert Holtz in 1994. Wexford provides investment advice to a variety of private pooled investment vehicles over which the firm has discretionary trading authority. | Investment Managers | Portfolio Manager-Equities | |
National Institutes of Health
![]() National Institutes of Health General GovernmentGovernment National Institutes Of Health conducts & supports peer-reviewed medical research and science. The firm's scientists & researchers investigate on different ways to prevent diseases as well as the causes, treatments and cures for common and rare diseases. The company was founded in 1887 and is headquartered in Bethesda, MD. | General Government | Corporate Officer/Principal | |
University College London | College/University | Doctorate Degree |
Statistiques
Internationale
Etats-Unis | 22 |
Canada | 3 |
Israël | 2 |
Brésil | 2 |
Royaume-Uni | 2 |
Sectorielle
Finance | 9 |
Consumer Services | 9 |
Health Technology | 7 |
Technology Services | 3 |
Government | 2 |
Opérationnelle
Analyst-Equity | 10 |
Founder | 6 |
Corporate Officer/Principal | 5 |
Doctorate Degree | 5 |
Director/Board Member | 5 |
Relations les plus connectées
- Bourse
- Insiders
- Ellen M. Brady
- Connexions Sociétés